Su‐Fern Tan

940 total citations
29 papers, 477 citations indexed

About

Su‐Fern Tan is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Su‐Fern Tan has authored 29 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Hematology and 9 papers in Oncology. Recurrent topics in Su‐Fern Tan's work include Sphingolipid Metabolism and Signaling (21 papers), Acute Myeloid Leukemia Research (10 papers) and Drug Transport and Resistance Mechanisms (8 papers). Su‐Fern Tan is often cited by papers focused on Sphingolipid Metabolism and Signaling (21 papers), Acute Myeloid Leukemia Research (10 papers) and Drug Transport and Resistance Mechanisms (8 papers). Su‐Fern Tan collaborates with scholars based in United States, Egypt and Spain. Su‐Fern Tan's co-authors include David J. Feith, Thomas P. Loughran, Myles C. Cabot, Todd E. Fox, Mark Kester, Samy A.F. Morad, David F. Claxton, Jennifer M. Pearson, Shantu Amin and Dhimant Desai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Su‐Fern Tan

29 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su‐Fern Tan United States 16 348 103 101 96 67 29 477
Huihong You United States 10 274 0.8× 56 0.5× 70 0.7× 47 0.5× 67 1.0× 13 522
Shishinn Sun United States 11 245 0.7× 67 0.7× 107 1.1× 117 1.2× 51 0.8× 15 474
Andrea López United States 6 447 1.3× 66 0.6× 97 1.0× 134 1.4× 25 0.4× 10 607
Brittany C. Lipchick United States 9 380 1.1× 87 0.8× 100 1.0× 82 0.9× 52 0.8× 12 500
Sharoon Akhtar United States 10 244 0.7× 72 0.7× 95 0.9× 69 0.7× 38 0.6× 27 421
Aaron M. Domina United States 6 353 1.0× 64 0.6× 143 1.4× 54 0.6× 36 0.5× 9 429
Ceri M. Wiggins United Kingdom 9 405 1.2× 86 0.8× 112 1.1× 28 0.3× 61 0.9× 12 492
Kerstin Brinkmann Germany 14 411 1.2× 113 1.1× 143 1.4× 20 0.2× 51 0.8× 21 551
Christian Argueta United States 13 463 1.3× 36 0.3× 160 1.6× 132 1.4× 22 0.3× 27 631
Valérie Palissot Luxembourg 14 398 1.1× 73 0.7× 99 1.0× 61 0.6× 22 0.3× 22 567

Countries citing papers authored by Su‐Fern Tan

Since Specialization
Citations

This map shows the geographic impact of Su‐Fern Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Fern Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Fern Tan more than expected).

Fields of papers citing papers by Su‐Fern Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su‐Fern Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Fern Tan. The network helps show where Su‐Fern Tan may publish in the future.

Co-authorship network of co-authors of Su‐Fern Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Su‐Fern Tan. A scholar is included among the top collaborators of Su‐Fern Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su‐Fern Tan. Su‐Fern Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuboi, Kazuhito, Josefina Casas, Su‐Fern Tan, et al.. (2024). A fluorogenic substrate for the detection of lipid amidases in intact cells. Journal of Lipid Research. 65(3). 100520–100520. 1 indexed citations
2.
Kassai, Miki, et al.. (2024). The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism—An Unconventional Ally in Cancer Treatment. International Journal of Molecular Sciences. 25(18). 9825–9825. 1 indexed citations
3.
Fisher‐Wellman, Kelsey H., Miki Kassai, P. Darrell Neufer, et al.. (2023). Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia. Cancers. 15(6). 1883–1883. 5 indexed citations
4.
Tan, Su‐Fern, Todd E. Fox, Jeremy J.P. Shaw, et al.. (2023). Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia. Cancers. 15(24). 5866–5866. 3 indexed citations
5.
Aruleba, Raphael Taiwo, Kelsey McLaughlin, Margaret Nelson, et al.. (2023). Pan-tissue mitochondrial phenotyping reveals lower OXPHOS expression and function across cancer types. Scientific Reports. 13(1). 16742–16742. 3 indexed citations
6.
Xing, Jeffrey C., Cait E. Hamele, Ross C. Hardison, et al.. (2022). Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia. Blood. 139(20). 3058–3072. 37 indexed citations
7.
Tan, Su‐Fern, Todd E. Fox, Jeremy J.P. Shaw, et al.. (2022). Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia. Blood Reviews. 55. 100950–100950. 12 indexed citations
8.
Tan, Su‐Fern, Pavan Kumar Dhanyamraju, Zheng Zeng, et al.. (2020). The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia. Frontiers in Oncology. 10. 393–393. 16 indexed citations
9.
Pearson, Jennifer M., Su‐Fern Tan, Arati Sharma, et al.. (2019). Ceramide Analogue SACLAC Modulates Sphingolipid Levels and MCL-1 Splicing to Induce Apoptosis in Acute Myeloid Leukemia. Molecular Cancer Research. 18(3). 352–363. 23 indexed citations
10.
Morad, Samy A.F., Miki Kassai, Todd E. Fox, et al.. (2019). Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells. Journal of Lipid Research. 60(9). 1590–1602. 25 indexed citations
11.
Tan, Su‐Fern, Xin Liu, Todd E. Fox, et al.. (2019). Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation. Journal of Lipid Research. 60(6). 1078–1086. 37 indexed citations
12.
Morad, Samy A.F., David J. Feith, Su‐Fern Tan, et al.. (2019). Pivotal role of mitophagy in response of acute myelogenous leukemia to a ceramide-tamoxifen-containing drug regimen. Experimental Cell Research. 381(2). 256–264. 17 indexed citations
13.
Olson, Kristine C., et al.. (2018). Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia. PLoS ONE. 13(2). e0193429–e0193429. 15 indexed citations
14.
Sharma, Arati, Kenichiro Doi, Shailaja Hegde, et al.. (2017). SKI-178: A multitargeted inhibitor of sphingosine kinase and microtubule dynamics demonstrating therapeutic efficacy in acute myeloid leukemia models. SHILAP Revista de lepidopterología. 3(4). 109–109. 23 indexed citations
15.
Tan, Su‐Fern, Jennifer M. Pearson, David J. Feith, & Thomas P. Loughran. (2017). The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia. Expert Opinion on Therapeutic Targets. 21(6). 583–590. 26 indexed citations
16.
Morad, Samy A.F., Su‐Fern Tan, David J. Feith, et al.. (2017). Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer. Biochemical Pharmacology. 130. 21–33. 20 indexed citations
17.
Morad, Samy A.F., P. Darrell Neufer, Tonya N. Zeczycki, et al.. (2016). Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia. Journal of Lipid Research. 57(7). 1231–1242. 23 indexed citations
18.
Morad, Samy A.F., Su‐Fern Tan, David J. Feith, et al.. (2015). Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia—Impact on enzyme activity and response to cytotoxics. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851(7). 919–928. 23 indexed citations
19.
Morad, Samy A.F., Jonathan C. Levin, Su‐Fern Tan, et al.. (2013). Novel off-target effect of tamoxifen — Inhibition of acid ceramidase activity in cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(12). 1657–1664. 47 indexed citations
20.
Watters, Rebecca, Todd E. Fox, Su‐Fern Tan, et al.. (2012). Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia. Leukemia & lymphoma. 54(6). 1288–1296. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huihong You Breakdown of academic impact, for papers by Shishinn Sun Breakdown of academic impact, for papers by Andrea López Breakdown of academic impact, for papers by Brittany C. Lipchick Breakdown of academic impact, for papers by Sharoon Akhtar Breakdown of academic impact, for papers by Aaron M. Domina Breakdown of academic impact, for papers by Ceri M. Wiggins Breakdown of academic impact, for papers by Kerstin Brinkmann Breakdown of academic impact, for papers by Christian Argueta Breakdown of academic impact, for papers by Valérie Palissot
Rankless by CCL
2026